All In Biotech

Drug Trial Radar · NCT02782663

A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease

A Phase 2, Multicenter, Open-Label Extension (OLE) Study to Observe the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Subjects With Crohn's Disease

Last checked: Nov 20, 2026Latest source record: Aug 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

107

Actual

Start

May 18, 2016

Primary completion

Jul 18, 2025

Study completion Jul 18, 2025

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
May 25, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a open-label extension (OLE) study designed to evaluate the long-term efficacy, safety, and tolerability of Upadacitinib (ABT-494).

Conditions

  • Crohn's Disease (CD)

Interventions

  • ABT-494Drug

    Tablet: Oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Achieving Endoscopic Remission at Month 12Time frame: Month 12
  2. Percentage of Participants Achieving Clinical Remission at Month 12Time frame: Month 12

Locations

61 sites in 18 countries. Site status is shown where the registry gives one.

  • UC San Diego Health System /ID# 150041

    La Jolla, California

  • Univ California, San Francisco /ID# 149987

    San Francisco, California

  • Duplicate_University of Florida - Archer /ID# 150033

    Gainesville, Florida

  • The Ctr for Gastro Disorders /ID# 150012

    Hollywood, Florida

  • Nature Coast Clinical Research - Inverness /ID# 149975

    Inverness, Florida

  • Gastroenterology Associates of Central Georgia, LLC /ID# 149870

    Macon, Georgia

  • GI Specialists of GA, PC /ID# 150015

    Marietta, Georgia

  • Cotton O'Neil Clinical Research Center, Digestive Health /ID# 149900

    Topeka, Kansas

  • Duplicate_University of Louisville /ID# 149884

    Louisville, Kentucky

  • Investigative Clinical Research /ID# 149886

    Annapolis, Maryland

  • Charm City Research Group /ID# 150040

    Towson, Maryland

  • Clin Res Inst of Michigan, LLC /ID# 150008

    Chesterfield, Michigan

  • Mayo Clinic - Rochester /ID# 149894

    Rochester, Minnesota

  • Kansas City Research Institute /ID# 149888

    Kansas City, Missouri

  • Washington University-School of Medicine /ID# 149899

    St Louis, Missouri

  • NYU Langone Long Island Clinical Research Associates /ID# 149976

    Lake Success, New York

  • Weill Cornell Medicine/NYP /ID# 149895

    New York, New York

  • Univ NC Chapel Hill /ID# 149982

    Chapel Hill, North Carolina

  • University Of Cincinnati Medical Center /ID# 149977

    Cincinnati, Ohio

  • Options Health Research, LLC /ID# 150010

    Tulsa, Oklahoma

  • Texas Digestive Disease Consultants - Southlake /ID# 149869

    Southlake, Texas

  • Texas Digestive Disease Consultants - Southlake /ID# 149989

    Southlake, Texas

  • Aspen Clinical Research /ID# 150020

    Orem, Utah

  • University of Virginia /ID# 149881

    Charlottesville, Virginia

  • Virginia Mason Hospital & Medical Center /ID# 150042

    Seattle, Washington

  • University of Washington /ID# 149988

    Seattle, Washington

  • Wisconsin Center for Advanced Research /ID# 149863

    Milwaukee, Wisconsin

  • Duplicate_CHU de Liege /ID# 149912

    Liège, Liege, Belgium

  • University of Alberta Hospital /ID# 149873

    Edmonton, Alberta, Canada

  • University of British Columbia (UBC) - Gordon and Leslie Diamond Health Care Ce /ID# 149876

    Vancouver, British Columbia, Canada

  • Duplicate_(G.I.R.I.) GI Research Institute Foundation /ID# 149878

    Vancouver, British Columbia, Canada

  • Toronto Digestive Disease Associates /ID# 149877

    Vaughan, Ontario, Canada

  • Disc_Royal Victoria Hospital / McGill University Health Centre /ID# 149871

    Montreal, Quebec, Canada

  • Hepato-Gastroenterologie HK, s.r.o. /ID# 149882

    Hradec Králové, Hradec Kralove, Czechia

  • Kobenhavns Universitet - Hvidovre Hospital (HH) /ID# 149890

    Hvidovre, Capital Region, Denmark

  • Duplicate_Aarhus University Hospital /ID# 149919

    Aarhus N, Central Jutland, Denmark

  • Duplicate_CHRU Nancy - Hopitaux de Brabois /ID# 149896

    Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France

  • CHRU Lille - Hopital Claude Huriez /ID# 149897

    Lille, Nord, France

  • Duplicate_CHU Amiens-Picardie Site Sud /ID# 149921

    Amiens, Somme, France

  • DRK Kliniken Berlin Westend /ID# 149905

    Berlin, Germany

Showing 40 of 61 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.